Thompson Davis & Co’s LeMaitre Vascular LMAT Stock Holding History

Thompson Davis & Co’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-764	Closed	-$13K	–	1120
2015 Q4	$13K	Buy	764 +202	+36%	+$2.92K	0.02%	595
2015 Q3	$7K	Buy	562 +1	+0.2%	+$13	0.01%	766
2015 Q2	$7K	Buy	561 +4	+0.7%	+$39	0.01%	814
2015 Q1	$5K	Hold	557	–	–	0.01%	897
2014 Q4	$4K	Sell	557 -5,779	-91%	-$41.4K	﹤0.01%	991
2014 Q3	$44K	Sell	6,336 -24,253	-79%	-$181K	0.06%	288
2014 Q2	$253K	Sell	30,589 -11,971	-28%	-$93.6K	0.37%	71
2014 Q1	$344K	Sell	42,560 -7,522	-15%	-$60.2K	0.57%	40
2013 Q4	$401K	Buy	+50,082	New	+$387K	0.61%	36

Other funds holding LMAT

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thompson Davis & Co's LMAT Position: Q1 2016 in Review

Thompson Davis & Co sold out of LeMaitre Vascular (LMAT) in Q1 2016, closing a stake of 764 shares — an estimated $13K sold.

Thompson Davis & Co first reported a position in LMAT in Q4 2013 and held it in 9 quarters. The position peaked at $401K in Q4 2013. 95 funds tracked by Wall St. Rank hold LMAT as of Q1 2016.

Thompson Davis & Co reported no remaining LeMaitre Vascular position as of Q1 2016 after selling out during the quarter.
Thompson Davis & Co sold 764 LeMaitre Vascular shares in Q1 2016, an estimated $13K.
Thompson Davis & Co first reported a position in LeMaitre Vascular in Q4 2013 and held it in 9 quarters.
Thompson Davis & Co's LeMaitre Vascular position peaked at $401K in Q4 2013.
95 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2016.

Based on Thompson Davis & Co's 13F filing for Q1 2016, filed 2 May 2016.